» Articles » PMID: 28228490

Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella Pertussis

Overview
Specialty Microbiology
Date 2017 Feb 24
PMID 28228490
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

is a Gram-negative bacterium that causes respiratory infections in humans. Ongoing molecular surveillance of acellular vaccine (aP) antigens is critical for understanding the interaction between evolutionary pressures, disease pathogenesis, and vaccine effectiveness. Methods currently used to characterize aP components are relatively labor-intensive and low throughput. To address this challenge, we sought to derive aP antigen genotypes from minimally processed short-read whole-genome sequencing data generated from 40 clinical isolates and analyzed using the SRST2 bioinformatic package. SRST2 was able to identify aP antigen genotypes for all antigens with the exception of pertactin, possibly due to low read coverage in GC-rich low-complexity regions of variation. Two main genotypes were observed in addition to a singular third genotype that contained an 84-bp deletion that was identified by SRST2 despite the issues in allele calling. This method has the potential to generate large pools of molecular data that can be linked to clinical and epidemiological information to facilitate research of vaccine effectiveness and disease severity in the context of emerging vaccine antigen-deficient strains.

Citing Articles

Tatajuba: exploring the distribution of homopolymer tracts.

de Oliveira Martins L, Bloomfield S, Stoakes E, Grant A, Page A, Mather A NAR Genom Bioinform. 2022; 4(1):lqac003.

PMID: 35118377 PMC: 8808543. DOI: 10.1093/nargab/lqac003.


Comparative genomics of whole-cell pertussis vaccine strains from India.

Alai S, Ghattargi V, Gautam M, Patel K, Pawar S, Dhotre D BMC Genomics. 2020; 21(1):345.

PMID: 32381023 PMC: 7204287. DOI: 10.1186/s12864-020-6724-8.

References
1.
Mooi F, HALLANDER H, Wirsing von Konig C, Hoet B, Guiso N . Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis. 2000; 19(3):174-81. DOI: 10.1007/s100960050455. View

2.
Decker M, Edwards K, Steinhoff M, Rennels M, Pichichero M, Englund J . Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics. 1995; 96(3 Pt 2):557-66. View

3.
Hegerle N, Dore G, Guiso N . Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Vaccine. 2014; 32(49):6597-600. DOI: 10.1016/j.vaccine.2014.09.068. View

4.
Sealey K, Harris S, Fry N, Hurst L, Gorringe A, Parkhill J . Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. J Infect Dis. 2014; 212(2):294-301. DOI: 10.1093/infdis/jiu665. View

5.
Mooi F, van Oirschot H, Heuvelman K, van der Heide H, Gaastra W, Willems R . Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998; 66(2):670-5. PMC: 107955. DOI: 10.1128/IAI.66.2.670-675.1998. View